Depakote News

Federal judge accepts Depakote settlement

October 10th, 2012

A Federal judge in Virginia has approved a Depakote settlement amounting to more than $1.6 billion dollars. Abbott Laboratories, the manufacturer of the drug, will pay $700 million in fines for illegally marketing Depakote. The company has already been ordered to pay more than $900 million in a civil settlement that included paying states for violating consumer protection laws. More »

Abbott agrees to $1.5 billion settlement in federal Depakote lawsuit

June 14th, 2012

The manufacturer of epilepsy drug Depakote admitted to engaging in off-label marketing of the drug and agreed to pay $1.5 billion in a settlement with the Department of Justice. Abbott Laboratories will pay a $500 million criminal fine and forfeit $199 million in assets. The company will also pay $560 million to the federal government and $239 million to participating states who alleged that the company violated consumer protection laws. More »

States investigate Abbott for possible illegal Depakote marketing

April 16th, 2012

Attorneys general from eight states have formed a committee to investigate potentially illegal marketing practices by the manufacturer of the anti-epileptic drug Depakote. The states involved—Texas, Florida, Illinois, Ohio, North Carolina, South Carolina, Oregon, and Pennsylvania—believe Abbott Laboratories may have violated state consumer protection laws by illegally marketing the drug for unapproved uses. More »

Abbott agrees to $1.3B settlement in Depakote lawsuits

October 25th, 2011

The manufacturer of Depakote has agreed to pay $1.3 billion to settle claims that it illegally marketed the drug for unapproved uses, sources say. Depakote lawsuits filed by the Justice Department and 24 states allege that Abbott Laboratories marketed the drug for aggression in dementia patients and other conditions not approved by the Food and Drug Administration. More »

U.S. in talks to settle Depakote lawsuit over off-label marketing

October 13th, 2011

U.S. Justice Department lawyers are conducting settlement discussions with Abbott Laboratories concerning a Depakote lawsuit filed against the company. The Justice Department alleges that Abbott Laboratories illegally marketed the drug Depakote for unapproved uses. More »

Depakote Birth Defects Website Launched By Hissey Kientz, LLP

September 26th, 2011

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Depakote Birth Defects Lawsuits. The site will serve as a news and information resource for women and their families who have been affected by birth defects linked to the use of Depakote during pregnancy. More »

Family files Depakote lawsuit over daughters’ birth defects

August 5th, 2011

The parents of two young girls who were born with birth defects have filed a lawsuit against the manufacturer of the anti-epilepsy drug Depakote. Roger and Mindy Pyszkowski allege that Mindy’s use of Depakote during pregnancy caused their daughters to be born with spina bifida and neural tube defects. More »

FDA warns of Depakote link to lower IQ scores

June 30th, 2011

The Food and Drug Administration has warned that children whose mothers used Depakote or similar drugs during pregnancy are more likely to have lower cognitive test scores than those who were exposed to other anti-seizure medications. In addition to its use on seizures, Depakote is also prescribed to treat bipolar disorder and migraine headaches. More »

Families file Depakote class action lawsuit in Illinois

April 21st, 2011

A Depakote class action lawsuit was filed recently in Illinois on behalf of the parents of children who were born with birth defects caused by the drug. The lawsuit alleges that the manufacturers of Depakote failed to properly warn about the risk of birth defects associated with using Depakote while pregnant. More »

Study finds increased birth defects risk with Depakote

June 10th, 2010

The use of the drug Depakote during pregnancy may increase the risk of spina bifida and five other types of birth defects, a new study has found. Researchers from the University of Groningen in The Netherlands wrote that due to the risk of causing birth defects, the use of Depakote should be avoided during pregnancy. More »

Page 1 of 212
I am currently represented by an attorney
*Required fields